What benefits should be weighed when deciding whether to discontinue breastfeeding or desloratadine treatment?

When deciding whether to discontinue breastfeeding or discontinue or abstain from Neoclarityn (desloratadine), weigh breastfeeding’s benefit for the child against treatment’s benefit for the woman, noting that desloratadine has been identified in breastfed newborns/infants and its effects on them are unknown.